| scholarly article | Q13442814 |
| retracted paper | Q45182324 |
| P356 | DOI | 10.1681/ASN.2007020198 |
| P698 | PubMed publication ID | 18003778 |
| P50 | author | Johan Van Der Vlag | Q43142256 |
| P2093 | author name string | Toin H van Kuppevelt | |
| Joost F M Lensen | |||
| Tessa J M Wijnhoven | |||
| Lambert P W J van den Heuvel | |||
| Dirk J Lefeber | |||
| Jo H M Berden | |||
| Angelique L W M M Rops | |||
| Ronnie G P Wismans | |||
| P2860 | cites work | Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane | Q24314924 |
| Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney | Q24540314 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane | Q28252874 | ||
| Regulated diversity of heparan sulfate | Q28282444 | ||
| Order out of chaos: assembly of ligand binding sites in heparan sulfate | Q29620085 | ||
| Human single chain antibodies against heparin: selection, characterization, and effect on coagulation | Q30827306 | ||
| Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney | Q32064386 | ||
| Recent insights into the structure and functions of heparan sulfate proteoglycans in the human glomerular basement membrane | Q33733897 | ||
| Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria | Q33826485 | ||
| Direct measurement of osmotic pressure of glycosaminoglycan solutions by membrane osmometry at room temperature. | Q34350989 | ||
| Nature of the glomerular capillary injury in human membranous glomerulopathy | Q34527436 | ||
| Dialysis membranes today. | Q34695681 | ||
| Pathophysiology of proteinuria | Q35083600 | ||
| How does the kidney filter plasma? | Q36072694 | ||
| Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion | Q36203698 | ||
| Clogging of the glomerular basement membrane | Q36208939 | ||
| Developmental changes in heparan sulfate expression: in situ detection with mAbs | Q36532134 | ||
| Localization of sialic acid in kidney glomeruli: regionalization in the podocyte plasma membrane and loss in experimental nephrosis | Q37539840 | ||
| Membranes for dialysis | Q40379359 | ||
| Application of cationic probes for the ultrastructural localization of proteoglycans in basement membranes | Q40391482 | ||
| Assembly of the glomerular filtration surface. Differentiation of anionic sites in glomerular capillaries of newborn rat kidney | Q41338036 | ||
| Glomerular anionic charge in congenital nephrotic syndrome of the Finnish type | Q41672817 | ||
| A new enzymatic serum creatinine measurement based on an endogenous creatine-eliminating system | Q42250981 | ||
| Determination of the Sialic Acid Linkage Specificity of Sialidases Using Lectins in a Solid Phase Assay | Q43567173 | ||
| Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior | Q44760488 | ||
| Functional nature of glomerular injury in progressive diabetic glomerulopathy | Q45062968 | ||
| Effect of colloid volume expansion on glomerular barrier size-selectivity in humans | Q47210729 | ||
| Differential expression of agrin in renal basement membranes as revealed by domain-specific antibodies | Q47891468 | ||
| In vivo degradation of heparan sulfates in the glomerular basement membrane does not result in proteinuria. | Q50472415 | ||
| Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system. | Q53606143 | ||
| Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody. | Q54598050 | ||
| Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies | Q56895736 | ||
| Heparan sulfate proteoglycans are lost in patients with diabetic nephropathy | Q68014163 | ||
| The glycosaminoglycan content of renal basement membranes in the congenital nephrotic syndrome of the Finnish type | Q68058965 | ||
| A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats | Q68136806 | ||
| Altered glomerular permeability as a result of focal detachment of the visceral epithelium | Q70408065 | ||
| Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases | Q70580293 | ||
| Quantification and characterization of glycosaminoglycans at the nanogram level by a combined azure A-silver staining in agarose gels | Q71666348 | ||
| High-resolution ultrastructural study of the rat glomerular basement membrane in aminonucleoside nephrosis | Q71710012 | ||
| A codiffusing system as a novel model for capillary wall charge selectivity | Q71879730 | ||
| Loss of glomerular anionic sites and the development of albuminuria in rats with streptozotocin-induced diabetes | Q72728183 | ||
| Increased expression of heparanase in overt diabetic nephropathy | Q79272921 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 3119-3127 | |
| P577 | publication date | 2007-11-14 | |
| P1433 | published in | Journal of the American Society of Nephrology | Q17123893 |
| P1476 | title | Removal of heparan sulfate from the glomerular basement membrane blocks protein passage | |
| P478 | volume | 18 |
| Q37597721 | Diabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal Injury |
| Q35131205 | Glomerular proteinuria: a complex interplay between unique players |
| Q26766645 | Glycosaminoglycan remodeling during diabetes and the role of dietary factors in their modulation |
| Q35059448 | Heparan sulfate proteoglycans |
| Q38661556 | Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression |
| Q55331790 | Knockdown of Heparanase Suppresses Invasion of Human Trophoblasts by Activating p38 MAPK Signaling Pathway. |
| Q81279178 | Loss of heparan sulfate glycosaminoglycan assembly in podocytes does not lead to proteinuria |
| Q38111707 | Pathophysiology of the diabetic kidney. |
| Q37140616 | Proteinuria in diabetic kidney disease: a mechanistic viewpoint |
| Q37228168 | Revisiting the glomerular charge barrier in the molecular era. |
| Q35186489 | Role of the podocyte in proteinuria |
| Q89728547 | The Cell "Coat of Many Colors" |
| Q37852132 | The gel hypothesis applied to the rat renal capillary membranes: a review |
| Q42762271 | The interference of heparin on IEF-PAGE of erythropoietins |
| Q48649007 | The locally activated renin-angiotensin system is involved in albumin permeability in glomerular endothelial cells under high glucose conditions. |
| Q48054376 | The podocyte and the proteoglycan |
| Q41279888 | Urinary exosomes reveal protein signatures in hypertensive patients with albuminuria |
Search more.